Literature DB >> 21086570

Gastric juice acidity in upper gastrointestinal diseases.

Pei-Jung Lu1, Ping-I Hsu, Chung-Hsuan Chen, Michael Hsiao, Wei-Chao Chang, Hui-Hwa Tseng, Kung-Hung Lin, Seng-Kee Chuah, Hui-Chun Chen.   

Abstract

AIM: To search the independent factors determining gastric juice acidity and to investigate the acidity of gastric juices in various benign and malignant upper gastrointestinal diseases.
METHODS: Fasting gastric juice acidity of 165 healthy subjects and 346 patients with esophageal ulcer (n = 21), gastric ulcer (n = 136), duodenal ulcer (n = 100) or gastric cancer (n = 89) were measured and compared. Additionally, gastric specimens were taken from the antrum and body for rapid urease test and histological examination.
RESULTS: Multivariate analysis revealed that bile stain of gastric juice, high acute inflammatory score of the corpus, and atrophy of the corpus were independent risk factors for the development of gastric hypoacidity with odds ratios of 3.1 (95% CI: 1.3-7.3), 3.1 (95% CI: 1.2-7.9) and 3.5 (95% CI: 1.3-9.2). Esophageal ulcer and duodenal ulcer patients had a lower pH level (1.9 and 2.1 vs 2.9, both P < 0.05) of gastric juices than healthy subjects. In contrast, gastric ulcer and gastric cancer patients had a higher pH level (3.4 and 6.6 vs 2.9, both P < 0.001) than healthy controls. Hypoacidity existed in 22%, 5%, 29%, 5% and 88% of healthy subjects, esophageal ulcer, gastric ulcer, duodenal ulcer and gastric cancer patients, respectively.
CONCLUSION: Bile reflux, atrophy and dense neutrophil infiltrate of the corpus are three independent factors determining the acidity of gastric juice.

Entities:  

Mesh:

Year:  2010        PMID: 21086570      PMCID: PMC2988245          DOI: 10.3748/wjg.v16.i43.5496

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  31 in total

Review 1.  The effects of alcohol consumption upon the gastrointestinal tract.

Authors:  L Bujanda
Journal:  Am J Gastroenterol       Date:  2000-12       Impact factor: 10.864

2.  Increased gastric juice leukotriene B4, C4 and E4 concentrations in children with Helicobacter pylori colonization.

Authors:  E Kasirga; I Coker; S Aydogdu; R V Yağci; B Taneli; A Gousseinov
Journal:  Turk J Pediatr       Date:  1999 Jul-Sep       Impact factor: 0.552

3.  Effect of Helicobacter pylori density on inflammatory activity in stomach.

Authors:  R Fareed; Z Abbas; M A Shah
Journal:  J Pak Med Assoc       Date:  2000-05       Impact factor: 0.781

Review 4.  Digestion and absorption of protein.

Authors:  H J Freeman; Y S Kim
Journal:  Annu Rev Med       Date:  1978       Impact factor: 13.739

5.  Ten-year prospective follow-up study on the relationship between Helicobacter pylori infection and progression of atrophic gastritis, particularly assessed by endoscopic findings.

Authors:  N Sakaki; H Kozawa; N Egawa; Y Tu; M Sanaka
Journal:  Aliment Pharmacol Ther       Date:  2002-04       Impact factor: 8.171

Review 6.  Molecular and cellular mechanisms involved in Helicobacter pylori-induced inflammation and oxidative stress.

Authors:  Yuji Naito; Toshikazu Yoshikawa
Journal:  Free Radic Biol Med       Date:  2002-08-01       Impact factor: 7.376

Review 7.  Role of bacterial overgrowth in the stomach as an additional risk factor for gastritis.

Authors:  Gregory Naylor; Anthony Axon
Journal:  Can J Gastroenterol       Date:  2003-06       Impact factor: 3.522

Review 8.  Clinical practice. Gastroesophageal reflux disease.

Authors:  Peter J Kahrilas
Journal:  N Engl J Med       Date:  2008-10-16       Impact factor: 91.245

9.  Risk factors for ulcer development in patients with non-ulcer dyspepsia: a prospective two year follow up study of 209 patients.

Authors:  P-I Hsu; K-H Lai; G-H Lo; H-H Tseng; C-C Lo; H-C Chen; W-L Tsai; H-S Jou; N-J Peng; C-H Chien; J-L Chen; P-N Hsu
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

10.  Risks of interleukin-1 genetic polymorphisms and Helicobacter pylori infection in the development of gastric cancer.

Authors:  A Chen; C-N Li; P-I Hsu; K-H Lai; H-H Tseng; P-N Hsu; G-H Lo; C-C Lo; C-K Lin; I-R Hwang; Y Yamaoka; H-C Chen
Journal:  Aliment Pharmacol Ther       Date:  2004-07-15       Impact factor: 8.171

View more
  17 in total

1.  Computer modeling of gastric parietal cell: significance of canalicular space, gland lumen, and variable canalicular [K+].

Authors:  James M Crothers; John G Forte; Terry E Machen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-02-04       Impact factor: 4.052

Review 2.  Detection of digestive malignancies and post-gastrectomy complications via gastrointestinal fluid examination.

Authors:  Lei Huang; Aman Xu
Journal:  Front Med       Date:  2017-03-02       Impact factor: 4.592

Review 3.  A Quantitative Review and Meta-Models of the Variability and Factors Affecting Oral Drug Absorption-Part I: Gastrointestinal pH.

Authors:  Ahmad Y Abuhelwa; David J R Foster; Richard N Upton
Journal:  AAPS J       Date:  2016-08-05       Impact factor: 4.009

4.  Neglected role of hookah and opium in gastric carcinogenesis: a cohort study on risk factors and attributable fractions.

Authors:  Alireza Sadjadi; Mohammad H Derakhshan; Abbas Yazdanbod; Majid Boreiri; Mahbubeh Parsaeian; Masoud Babaei; Masoomeh Alimohammadian; Fatemeh Samadi; Arash Etemadi; Farhad Pourfarzi; Emad Ahmadi; Alireza Delavari; Farhad Islami; Farshad Farzadfar; Masoud Sotoudeh; Arash Nikmanesh; Behrooz Z Alizadeh; Geertruida H de Bock; Reza Malekzadeh
Journal:  Int J Cancer       Date:  2013-08-05       Impact factor: 7.396

5.  Monitoring of peri-distal gastrectomy carbohydrate antigen 19-9 level in gastric juice and its significance.

Authors:  A-Man Xu; Lei Huang; Wen-Xiu Han; Zhi-Jian Wei
Journal:  Int J Clin Exp Med       Date:  2014-01-15

6.  Population In Vitro-In Vivo Correlation Model Linking Gastrointestinal Transit Time, pH, and Pharmacokinetics: Itraconazole as a Model Drug.

Authors:  Ahmad Y Abuhelwa; Stuart Mudge; David Hayes; Richard N Upton; David J R Foster
Journal:  Pharm Res       Date:  2016-04-27       Impact factor: 4.200

7.  Buffer Therapy for Cancer.

Authors:  Maria de Lourdes C Ribeiro; Ariosto S Silva; Kate M Bailey; Nagi B Kumar; Thomas A Sellers; Robert A Gatenby; Arig Ibrahim-Hashim; Robert J Gillies
Journal:  J Nutr Food Sci       Date:  2012-08-15

Review 8.  Stability of allergens.

Authors:  Judith Pekar; Davide Ret; Eva Untersmayr
Journal:  Mol Immunol       Date:  2018-03-30       Impact factor: 4.407

9.  Development and Bio-Predictive Evaluation of Biopharmaceutical Properties of Sustained-Release Tablets with a Novel GPR40 Agonist for a First-in-Human Clinical Trial.

Authors:  Ewelina Juszczyk; Kamil Kisło; Paweł Żero; Ewa Tratkiewicz; Maciej Wieczorek; Jadwiga Paszkowska; Grzegorz Banach; Marcela Wiater; Dagmara Hoc; Grzegorz Garbacz; Jaroslaw Sczodrok; Dorota Danielak
Journal:  Pharmaceutics       Date:  2021-05-28       Impact factor: 6.321

Review 10.  Potential Applications of Chitosan-Based Nanomaterials to Surpass the Gastrointestinal Physiological Obstacles and Enhance the Intestinal Drug Absorption.

Authors:  Nutthapoom Pathomthongtaweechai; Chatchai Muanprasat
Journal:  Pharmaceutics       Date:  2021-06-15       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.